首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
C group hyperlipidemia相关文献:
Distribution of lipid levels and prevalence of hyperlipidemia: data from the NHANES 2007-2018.
Li Z, Zhu G, Chen G, Luo M, Liu X, Chen Z, Qian J.
Lipids Health Dis. 2022 Oct 28;21(1):111. doi: 10.1186/s12944-022-01721-y.
PMID:36307819
Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis.
Tummala R, Gupta M, Devanabanda AR, Bandyopadhyay D, Aronow WS, Ray KK, Mamas M, Ghosh RK.
Ann Med. 2022 Dec;54(1):1287-1296. doi: 10.1080/07853890.2022.2059559.
PMID:35533049
MicroRNA in cardio-metabolic disorders.
Su X, Nie M, Zhang G, Wang B.
Clin Chim Acta. 2021 Jul;518:134-141. doi: 10.1016/j.cca.2021.03.024. Epub 2021 Apr 3.
PMID:33823149
Prevalence and treatment of hyperlipidemia in patients with chronic hepatitis C infection.
Murthy GD, Vu K, Venugopal S.
Eur J Gastroenterol Hepatol. 2009 Aug;21(8):902-7. doi: 10.1097/MEG.0b013e32831b4698.
PMID:19398918
Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes.
Fan D, Li L, Li Z, Zhang Y, Ma X, Wu L, Qin G.
Lipids Health Dis. 2018 May 8;17(1):102. doi: 10.1186/s12944-018-0676-x.
PMID:29739462
2017 Taiwan lipid guidelines for high risk patients.
Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, Wang CY, Chao TH, Liu PY, Su CH, Chien SC, Liou CW, Tang SC, Lee CC, Yu TY, Chen JW, Wu CC, Yeh HI; Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients.
J Formos Med Assoc. 2017 Apr;116(4):217-248. doi: 10.1016/j.jfma.2016.11.013. Epub 2017 Feb 24.
PMID:28242176
Efficacy of Kushen decoction on high-fat-diet-induced hyperlipidemia in rats.
Jiri Mutu Z, Shilong L, Peng N, Yong'an L, Qinying AI, Xiaojun Y, Hongning L, Yanhua JI, Zhijun Z.
J Tradit Chin Med. 2022 Jun;42(3):364-371. doi: 10.19852/j.cnki.jtcm.20220225.002.
PMID:35610005
Protective role of thymoquinone in hyperlipidemia-induced liver injury in LDL-R(-/-)mice.
Wang F, Yao W, Yu D, Hao Y, Wu Y, Zhang X.
BMC Gastroenterol. 2023 Aug 11;23(1):276. doi: 10.1186/s12876-023-02895-0.
PMID:37568105
Mediterranean Dietary Treatment in Hyperlipidemic Children: Should It Be an Option?
Massini G, Capra N, Buganza R, Nyffenegger A, de Sanctis L, Guardamagna O.
Nutrients. 2022 Mar 23;14(7):1344. doi: 10.3390/nu14071344.
PMID:35405957
Liposomal Phytosterols as LDL-Cholesterol-Lowering Agents in Diet-Induced Hyperlipidemia.
Poudel A, Gachumi G, Paterson PG, El-Aneed A, Badea I.
Mol Pharm. 2023 Sep 4;20(9):4443-4452. doi: 10.1021/acs.molpharmaceut.2c01072. Epub 2023 Jul 26.
PMID:37492942
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3